guide

OptumRx prior authorization: how the approval process works

OptumRx prior authorization is a pharmacy coverage determination against the Prescription Drug List. OptumRx is not UnitedHealthcare medical, and the plan owns the appeal.
Jeffrey Morelli
Jeffrey Morelli
Published 22 July 2026

OptumRx is a pharmacy benefit manager, not a health plan. It sits inside Optum, which is part of UnitedHealth Group, and it administers the drug side of the benefit for UnitedHealthcare plans and for a long list of unrelated employers, health plans, and government sponsors that simply hired it. That structure explains most of the confusion pharmacy teams run into: the entity reviewing your request and the entity that will hear your appeal are frequently not the same company.

This guide is written for pharmacy technicians, billers, and prior authorization coordinators who push drug approvals through OptumRx at volume. Every section leads with the operative fact.

What OptumRx is

OptumRx is the pharmacy benefit manager operated by Optum, a UnitedHealth Group business. A PBM does not insure anybody. It is hired by a plan sponsor to build and maintain the drug list, contract with retail and mail pharmacies, adjudicate pharmacy claims at the point of sale, and run the clinical review that decides whether a restricted drug is covered for a given member.

Two consequences follow, and both of them cost teams time every week.

OptumRx is not UnitedHealthcare. It administers the pharmacy benefit for UnitedHealthcare plans, which is why the two names travel together so often. But it also administers the pharmacy benefit for employers, unions, and health plans that have no UnitedHealthcare relationship whatsoever. Seeing OptumRx on a card tells you who processes the drug claim. It tells you nothing about who covers the office visit, the infusion suite, or the surgery. If you need the medical side of a UnitedHealthcare member, that is a separate workflow with separate rules; start at the UnitedHealthcare prior authorization guide.

The plan owns the rules, OptumRx applies them. Coverage criteria, the drug list, and the appeal rights all belong to the plan sponsor. OptumRx executes against them. Two members can both hand you an OptumRx card and still face different tiers, different step requirements, and different appeal deadlines, because they belong to different plans. Never generalize a criteria set you learned on one OptumRx group to the next one.

The pharmacy card is the tell. Verify the BIN, PCN, and group on the pharmacy card, or run a test claim, before you assume which PBM and which plan you are dealing with.

What a pharmacy PA reviews

A pharmacy prior authorization is a coverage determination. The question is not whether the drug is a reasonable choice in the abstract; it is whether this plan covers this drug, at this dose and quantity, for this member, given the rules attached to the plan’s Prescription Drug List. Answer that question and the request clears. Argue clinical philosophy instead and it sits.

Four rule types drive nearly every restricted drug on an OptumRx-administered plan.

  • Tier placement. The Prescription Drug List sorts covered products into tiers that set cost share. A drug on a high tier is still covered; a drug that is absent from the list is not, and it needs a different request entirely.
  • Step therapy. The plan requires a preferred agent first. Approval turns on documenting what was tried, at what dose, for how long, and exactly how it failed. “Patient did not tolerate it” without a date and an outcome is the single most common reason a step request stalls.
  • Quantity limits. Coverage is capped per fill or per period. Exceeding the cap needs dose rationale tied to the diagnosis and the labeling, not just a prescriber’s preference.
  • Non-formulary exception. The drug is not on the list at all. This is a distinct request that asks the plan to cover something it otherwise does not, and it usually requires showing that listed alternatives are ineffective, contraindicated, or harmful for this member.

Clinical criteria also commonly test diagnosis specificity, prescriber specialty, baseline labs or imaging where the drug requires them, and age or weight parameters. The reviewer is reading against a written criteria document. Write the request so that a reviewer with no context can check each criterion off in order.

Pharmacy benefit vs medical benefit

Before you touch a form, decide which benefit the drug lives under. Get this wrong and the request goes to an organization that has no authority to approve it.

How the drug is obtained Benefit Who reviews
Dispensed by a retail or mail pharmacy against the pharmacy card Pharmacy OptumRx, as the plan’s PBM
Self-administered specialty drug shipped to the member or the office Pharmacy OptumRx, usually with Optum Specialty Pharmacy as the dispensing channel
Purchased by the practice, administered in the clinic, billed with a HCPCS J-code (buy and bill) Medical The member’s health plan or its delegated reviewer, not the PBM
Administered in a hospital outpatient or infusion setting Medical The member’s health plan or its delegated reviewer, not the PBM

Some drugs can travel either route depending on the plan design and the site of care, which is why the coverage question is really a site-of-care question. When a request bounces with a benefit mismatch, the fix is almost never a stronger clinical letter. It is resubmission to the correct benefit with the correct code set: NDC for the pharmacy side, HCPCS J-code for the medical side.

Working prior authorization across more than one payer? Start with Silna’s complete guide to prior authorization.

How to submit

OptumRx accepts prior authorization requests through its provider portal, through electronic prior authorization platforms integrated with prescribing systems (CoverMyMeds is the one most pharmacy teams encounter), and by fax on the plan’s designated form. Electronic submission is worth the setup: it validates required fields, timestamps receipt, and gives you a status you can check without a phone call. Fax should be the fallback, not the habit, because a fax gives you no confirmation that the request was ever recognized as complete.

Whichever channel you use, a complete request carries the same payload:

  • Member ID and group exactly as printed on the pharmacy card, plus the BIN and PCN
  • Prescriber NPI, specialty, and a direct callback line for the reviewer
  • Drug name, strength, dosage form, NDC, directions, and the quantity requested per fill
  • ICD-10 diagnosis that matches the criteria, at the specificity the criteria require
  • Tried-and-failed history with dates: each prior agent, the dose, the duration, and the documented outcome
  • Dose rationale when the request exceeds a quantity limit, tied to the diagnosis and the labeling
  • Any labs, scores, or diagnostics the criteria name as prerequisites

The tried-and-failed history is where most requests are won or lost. Reviewers cannot infer a failure from an absence. Give each prior trial a start date, an end date, and a reason for stopping, and attach the chart note that supports it.

For specialty and limited-distribution products, the plan may route dispensing to Optum Specialty Pharmacy. Confirm the dispensing channel at the same time you confirm coverage, because an approved authorization that names the wrong pharmacy still leaves the member without the drug. Ask the reviewer to state the approval’s effective dates and quantity on the notice, and record them; a renewal filed after expiration is treated as a new request.

If a delay would jeopardize the member’s health, request an expedited review and say so explicitly, in clinical terms, at the time of submission. Expedited requests carry shorter decision windows than standard ones on every plan line, but only if the urgency is stated and supported.

How to appeal a denial

Two facts govern every OptumRx appeal.

First, sort the denial before you appeal it. If the request was denied because a field was blank, a code was wrong, the wrong benefit was billed, or the tried-and-failed history had no dates, that is an administrative problem. Fix it and resubmit. A formal appeal for a fixable defect is slower than a corrected resubmission and spends rights you may need later. Our denial code reference helps separate the two categories quickly.

Second, the appeal follows the plan, not the PBM. OptumRx applies the plan’s rules; it does not own the member’s appeal rights. Where the appeal goes depends entirely on what kind of plan the member has.

Plan type First level after the denial Levels above that
Medicare Part D Redetermination by the plan Independent Review Entity, then ALJ, then the Medicare Appeals Council, then federal court
Commercial and employer-sponsored Internal appeal per the plan’s own procedure External review where the plan or applicable law provides one
Medicaid managed care Plan appeal State fair hearing

The Medicare Part D sequence is fixed and worth memorizing, because it is the one path where the levels are set by regulation rather than by a plan document:

  1. Coverage determination. The initial decision on whether the plan covers the drug, including exception requests. A denial here is what starts the clock.

  2. Redetermination. A second look by the plan itself, requested within the window stated on the denial notice. Attach a prescriber statement that addresses the exact criterion that failed. A redetermination that repeats the original request usually produces the original answer.

  3. Reconsideration by an Independent Review Entity. An outside organization contracted by Medicare reviews the case. This is the first level outside the plan, and the first genuinely fresh set of eyes.

  4. Administrative Law Judge hearing. Available once the case meets the applicable amount-in-controversy threshold.

  5. Medicare Appeals Council, and after that, review in federal district court.

For commercial members, there is no universal sequence. The plan document controls the levels, the deadlines, and whether an external review exists. Read the denial notice: it is required to tell you what the next level is and how long you have. For the general mechanics that apply across payers, see our guide to appealing a prior authorization denial.

What changed for 2026

Three shifts matter for teams working OptumRx this year.

Drug prior authorization is not covered by the CMS electronic PA rule. The CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) pushes impacted payers toward FHIR-based prior authorization APIs and specific electronic denial reasons by January 1, 2027, and CMS has launched an Electronic Prior Authorization initiative around it. The prior authorization provisions of that rule do not reach drugs. Plan for pharmacy PA to keep running on today’s ePA platforms and portals even as the medical side modernizes around it, and confirm scope with your own vendors rather than assuming parity.

Voluntary reductions in prior authorization volume. Through 2025 and into 2026, major insurers and PBMs, including UnitedHealth Group’s businesses, publicly committed to trimming prior authorization requirements and standardizing electronic submission. What that means for any specific drug is decided at the plan level, so treat announcements as a prompt to re-check the current Prescription Drug List rather than as a rule you can rely on. Submitting a PA for a drug that no longer needs one creates work with no clinical purpose; assuming a drug is exempt when it is not creates a rejected claim at the counter.

Annual drug list churn. Prescription Drug Lists reset on the plan year. Tier moves, new step requirements, and outright removals take effect on renewal, and a member who filled a drug without friction in December can hit a step edit in January on the same plan. Pull the current list for the specific group at the start of each plan year rather than trusting last year’s criteria.

How Silna Reduces Denials

Avoidable OptumRx denials cluster around three preventable causes, and all three are visible before the request leaves the practice. The first is a benefit mismatch, where a buy-and-bill drug is sent to the PBM or a pharmacy-benefit drug is billed to the medical plan. The second is an incomplete tried-and-failed history, where prior therapies appear with no dates, doses, or documented outcomes. The third is a stale criteria set, where the request is built against last year’s Prescription Drug List rules.

Silna Health’s Care Readiness Platform automates the workflow end to end: benefits verification that identifies which benefit a drug actually sits under, form population, real-time error checking, and submission across channels. Silna’s Predictive Document Intelligence flags the documentation gaps and routing errors that reset timelines and burn appeal rights before a coordinator ever hits send. By combining automation with built-in payor communication, Silna cuts pre-visit administrative work by 95%, per Silna Health, 2026.

Silna’s strongest adoption is among ABA therapy, physical therapy, and mental health practices, plus care management for older adults, the settings where drug and medical authorizations land on the same coordinator and where the benefit split does the most damage. For teams working OptumRx alongside a dozen other payors, Silna coordinates the full workflow so the first submission is the complete submission. See how it applies to your payer mix at silnahealth.com.

Key terms

Pharmacy benefit manager (PBM)
A company hired by a plan to run the drug benefit: the drug list, the pharmacy network, claim adjudication, and clinical review. OptumRx is one.
Coverage determination
The decision on whether a plan covers a drug for a member. A pharmacy prior authorization is a type of coverage determination.
Prescription Drug List
The formulary: the covered drugs and the tier and restriction rules attached to each. Set by the plan, applied by OptumRx, refreshed on the plan year.
Step therapy
A fail-first rule requiring a preferred agent before a restricted one. Approval turns on dated documentation of the prior trial and its outcome.
Formulary exception
A request to cover a drug that is not on the list, or to waive a restriction, based on why listed alternatives will not work for this member.
Optum Specialty Pharmacy
The Optum dispensing channel plans commonly designate for specialty and limited-distribution drugs. A dispensing channel, not a reviewer.
Redetermination
The first appeal level in Medicare Part D: a second review by the plan, filed within the window on the denial notice.

Frequently Asked Questions

Does an OptumRx card mean my patient has UnitedHealthcare?

No. OptumRx is a pharmacy benefit manager inside Optum and UnitedHealth Group, and it administers the pharmacy benefit for UnitedHealthcare plans and for many unrelated employers and health plans. An OptumRx logo tells you who processes the drug claim, not who covers the medical services. Check the medical card separately, and confirm the plan sponsor before you assume the criteria or the appeal path.

Does OptumRx review imaging, procedures, or surgery?

No. OptumRx reviews drug coverage only. Medical services go to the member’s health plan or whichever reviewer that plan uses. The one place the line blurs is drugs: a drug bought and billed in a clinic under a HCPCS J-code is a medical benefit claim and does not go to the PBM, while the same molecule dispensed by a pharmacy against the pharmacy card does.

Where do I submit an OptumRx prior authorization?

Through the OptumRx provider portal, through an electronic prior authorization platform integrated with your prescribing system such as CoverMyMeds, or by fax on the plan’s designated form. Prefer electronic submission: it validates required fields, timestamps receipt, and returns a status you can check without calling. Confirm the current channel and form for the specific plan, because the sponsor can designate its own.

If OptumRx denies the drug, who hears the appeal?

The plan, not OptumRx. Appeal rights belong to the member’s plan, and OptumRx applies the plan’s rules rather than owning them. For Medicare Part D, the sequence runs coverage determination, redetermination by the plan, reconsideration by an Independent Review Entity, an Administrative Law Judge hearing, the Medicare Appeals Council, and federal court. For commercial coverage, the plan document sets the levels and the deadlines, and the denial notice tells you what comes next.

What is the most common preventable reason a request gets denied?

An undated tried-and-failed history on a step therapy request. Reviewers cannot infer a failure from an absence, so “patient did not tolerate it” with no dose, duration, or outcome fails the criterion on its face. Give every prior agent a start date, an end date, a dose, and a documented reason for stopping, and attach the supporting note. Benefit mismatches and stale drug list criteria are the next two.

This article is general educational information, not medical or insurance advice. Coverage rules and clinical criteria vary by plan and state, so consult a licensed healthcare professional or your plan administrator about your specific situation.

About the author

Jeffrey Morelli

Jeffrey Morelli is the Co-Founder and CEO of Silna Health, the first Care Readiness Platform built to remove the administrative barriers that delay care. Silna automates benefit checks, eligibility, and prior authorizations across 1,000+ payors, and is backed by $27M from Accel and Bain Capital Ventures. Before Silna, Jeff spent a decade in San Francisco building and scaling products for highly regulated industries, including leading go-to-market at Truework (Series C, acquired by Checkr).

Last reviewed: July 12, 2026.